IP Library › Assignment 038427/0268
Patent Assignment
Reel/Frame 038427/0268

Change of Name

Recorded: 2016-04-13 Pages: 3
Assignor
N30 PHARMACEUTICALS, INC.
Executed: 2015-02-11
Assignee
NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRCLE, BOULDER, COLORADO, 80301
Covered Property (1)
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,433,618 →
Application: 15/097,378 →
Publication: US 2016/0220556
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Apr 13, 2016
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 038427/0258 →
Assignment of Assignor's Interest Apr 13, 2016
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 038427/0652 →
Assignment of Assignor's Interest Jul 13, 2018
From: ALPINE IMMUNE SCIENCES, INC.
To: LAUREL VENTURE CAPITAL LTD.
Reel/Frame 046341/0795 →
Assignment of Assignor's Interest Apr 4, 2019
From: LAUREL VENTURE CAPITAL LTD.
To: LAUREL THERAPEUTICS LTD.
Reel/Frame 048787/0883 →